	Pelvic lymph node dissection during robot-assisted radical prostatectomy: a bibliometric analysis of surgical extent, nodal staging, and lymphatic morbidity. J Robot Surg Zhao Y, Wang W, Dong Z. PMID: 42545410 [PubMed - indexed for MEDLINE]
	Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden. Scand J Urol Hawez L, Bergengren O, Ahlberg M, Garmo H, Van Hemelrijck M, Nyberg UK, Gardmark T, Holmberg L, Liedberg F, Bill-Axelson A. PMID: 42545334 [PubMed - indexed for MEDLINE]
	The PROTEUS trial: envisioning the future of perioperative therapy and radical prostatectomy for high-risk prostate cancer. Official position of the Italian Society of Urology (SIU). Minerva Urol Nephrol Novara G, Albisinni S, Campi R, Larcher A, DE Lorenzis E, Pandolfo SD, Pavan N, Zattoni F, Dal Moro F, Antonelli A, Ficarra V, Minervini A, Mirone V, Rocco B, Salonia A, Tubaro A, Carrieri G, Porpiglia F. PMID: 42545136 [PubMed - as supplied by publisher]
	Real-World Outcomes of Radium-223 Therapy in Metastatic Castration-Resistant Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide Continuation. Int J Urol Abe K, Miyazawa Y, Nakazawa S, Onose M, Maeno Y, Tsuji Y, Kanayama A, Ohtsu A, Fujizuka Y, Arai S, Nomura M, Sekine Y, Koike H, Matsui H, Suzuki K. PMID: 42544862 [PubMed - indexed for MEDLINE]
	Present status of prostate cancer diagnosis, limitations, challenges, and future endeavors. Ann Med Hooda K, Chatterjee M, Sharma AP, Aggarwal N, Sharma J. PMID: 42544420 [PubMed - indexed for MEDLINE]
	Cultural Factors Influencing Prostate Cancer Screening Uptake in Urban Ogun State, Nigeria: A Review of Evidence. Niger Med J Aluko-Arowolo S, Oyafunke-Omoniyi C, Tamuno-Opubo AT, Tobi AA, Nwaobilor OS. PMID: 42544271 [PubMed]
	[The diagnostic complexity of paraneoplastic thrombotic thrombocytopenic purpura]. Rev Med Liege Delcour A, Jadot L, Aït Moussa N, Herman L, Perlot Q. PMID: 42544062 [PubMed - indexed for MEDLINE]
	TFE3-DualNet: An Interpretable Foundation Model-Based Deep Learning Ensemble for Diagnosing TFE3-Rearranged Renal Cell Carcinoma From Whole-Slide Images in a Two-Center Cohort. Cancer Med Chen YH, Xu QH, Yao HH, Liu KZ, Gui CP, Fu LM, Wang YH, Zhu JQ, Li JC, Chen MY, Huang KB, Lin HS, Liao B, Cao Y, Wei JH, Li PJ, Luo JH, Cao JZ. PMID: 42543505 [PubMed - indexed for MEDLINE]
	Treatment of Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy. Prostate Schaldemose EL, Poulsen MH, Nørby B, Madsen CV. PMID: 42542970 [PubMed - as supplied by publisher]
	Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer. Prostate Scheipner L, Baudo A, Jannello LMI, Siech C, Angelis M, Bello FD, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Carmignani L, Cobelli O, Longo N, Mischinger J, Ahyai S, Karakiewicz PI. PMID: 42542968 [PubMed - as supplied by publisher]
	Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era. Prostate McMaster T, Louey CYM, Santucci J, Hobson C, Chen DD, Sathianathen N, Ischia J, Bolton DM, Lawrentschuck N, Murphy DG, Siva S, Perera M. PMID: 42542964 [PubMed - as supplied by publisher]
	Predictive Value of [-2]proPSA-Related Indices for Prostate Cancer Detection Years Before Prostate-Specific Antigen Elevation: Insights From a Five-Year Longitudinal Screening Cohort. Prostate Sekine Y, Fujizuka Y, Nakazawa S, Tsuji Y, Ohtsu A, Miyazawa Y, Arai S, Nomura M, Koike H, Matsui H, Ito K, Suzuki K. PMID: 42542963 [PubMed - as supplied by publisher]
	En-bloc Resection of Bladder Tumor Versus Conventional Transurethral Resection of Bladder Tumor: Long-term Oncological Outcomes from a Single-center Prospective Trial. Eur Urol Focus Di Bello F, Diana P, Gallioli A, Territo A, Rodriguez-Faba Ó, Gaya JM, Huguet J, Belarmino AR, Lopez M, Avesani G, Graps G, Algaba F, Palou J, Breda A. PMID: 42542426 [PubMed - as supplied by publisher]
	Tissue Memory Score captures proximal tubular identity loss and independently stratifies survival in clear cell renal cell carcinoma. Urol Oncol Khalil S, Hamdan M. PMID: 42542400 [PubMed - as supplied by publisher]
	Comment on "Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial". World J Urol Yusuf SM, Sattar A, Sharabu R. PMID: 42541579 [PubMed - in process]
	Reirradiation of locally recurrent prostate Cancer: a review of prospective evidence and delineation and planning strategies from the reirradiation Collaborative group (ReCOG). Clin Transl Radiat Oncol Slevin F, Warkentin B, Hansen J, Henry AM, Murray LJ, Murrell DH, Ong WL, Pasquier D. PMID: 42540621 [PubMed]
	Diagnosis of metastatic prostate cancer by supraclavicular lymph node excision in a patient with persistent macroscopic hematuria: A case report. Urol Case Rep Drozda V, Cierna Z, Harmanos M, Cvik M. PMID: 42540607 [PubMed]
	Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and InÂ Vitro Verification. Cancer Med Sakai T, Kawasaki Y, Sakamoto I, Hishinuma E, Matsukawa N, Chiba D, Sato T, Morozumi K, Maekawa M, Mano N, Ito A. PMID: 42538613 [PubMed - indexed for MEDLINE]
	Performance of Urine Tumor DNA Detection in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Repeat Transurethral Resection. Eur Urol Focus Ogunkeye J, Shkolyar E, Mach KE, Prendiville S, Prado K, Shah JB, Skinner EC, Fischer DS, Phillips KG, Bicocca VT, Levin TG, Liao JC. PMID: 42538173 [PubMed - as supplied by publisher]
	Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance. Cancer Treat Res Commun Bogale DE. PMID: 42537446 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180462

Page 1 of 9024



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy